Skip to main content
رجوع
CNTA logo

Centessa Pharmaceuticals plc

جودة البيانات: 100%
CNTA
NASDAQ Healthcare Biotechnology
KWD 27.89
▲ KWD 1.95 (7.52%)
القيمة السوقية: 3.75B
نطاق اليوم
KWD 25.17 KWD 27.96
نطاق 52 أسبوعًا
KWD 9.60 KWD 30.58
حجم التداول
2,257,011
متوسط 50 يوم / 200 يوم
KWD 25.21 / KWD 21.69
الإغلاق السابق
KWD 25.94

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E -15.9 0.3
P/B 9.3 2.9
ROE % -73.9 3.7
Net Margin % — 3.8
Rev Growth 5Y % — 10.0
D/E 0.3 0.2

السعر المستهدف للمحللين

Hold
KWD 38.600 +38.4%
Low: KWD 35.000 High: KWD 42.000
ربحية السهم المستقبلية
-KWD 1.636
الإيرادات المقدّرة
2.2 M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2029 KWD 0.323
KWD 0.323 – KWD 0.323
 450 M 4
FY2028 -KWD 1.137
-KWD 2.878 – KWD 1.202
 170 M 11
FY2027 -KWD 1.731
-KWD 2.320 – -KWD 1.131
 23 M 13

Insider Trading Activity

20 transactions
Date Insider Type Shares Price Value
Feb 2, 2026
Bush Tia L
Chief Technology & Quality Ofc
 grant 175,000 — —
Feb 1, 2026
Bush Tia L
Chief Technology & Quality Ofc
 other 8,549 KWD 24.570 KWD 210,049
Dec 8, 2025
Accardi Mario Alberto
President, Orexin Program
 other 10,000 KWD 9.530 —
Dec 8, 2025
Accardi Mario Alberto
President, Orexin Program
 sell 10,000 KWD 30.000 KWD 300,000
Nov 17, 2025
HUSSAIN IQBAL J
General Counsel
 other 12,000 KWD 5.840 —
Nov 17, 2025
HUSSAIN IQBAL J
General Counsel
 sell 6,000 KWD 27.639 KWD 165,835
Nov 1, 2025
Accardi Mario Alberto
President, Orexin Program
 other 593 KWD 24.900 KWD 14,766
Sep 10, 2025
HUSSAIN IQBAL J
General Counsel
 other 40,000 KWD 5.840 —
Sep 10, 2025
HUSSAIN IQBAL J
General Counsel
 sell 20,000 KWD 22.000 KWD 440,000
Sep 9, 2025
HUSSAIN IQBAL J
General Counsel
 other 40,000 KWD 5.840 —
Sep 9, 2025
HUSSAIN IQBAL J
General Counsel
 sell 20,000 KWD 20.005 KWD 400,102
Aug 1, 2025
Accardi Mario Alberto
President, Orexin Program
 other 597 KWD 17.170 KWD 10,250
Jul 29, 2025
Accardi Mario Alberto
President, Orexin Program
 sell 8,322 KWD 15.231 KWD 126,751
Jul 25, 2025
Weinhoff Gregory M
Chief Business Officer
 other 20,000 KWD 3.850 —
Jul 25, 2025
Weinhoff Gregory M
Chief Business Officer
 sell 10,000 KWD 15.560 KWD 155,598
Jul 21, 2025
SAHA SAURABH
Chief Executive Officer
 other 110,000 KWD 3.850 —
Jul 21, 2025
SAHA SAURABH
Chief Executive Officer
 sell 55,000 KWD 15.920 KWD 875,600
Jul 15, 2025
HUSSAIN IQBAL J
General Counsel
 other 12,000 KWD 5.840 —
Jul 15, 2025
HUSSAIN IQBAL J
General Counsel
 sell 6,000 KWD 14.928 KWD 89,567
Jun 24, 2025
Accardi Mario Alberto
President, Orexin Program
 other 30,000 KWD 3.850 —

النقاط الرئيسية

Debt/Equity of 0.29 — conservative balance sheet
Negative free cash flow of -142.09M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-73.93%
ROIC-29.07%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.29
Current Ratio9.25
Interest Coverage-19.93

التقييم

P/E Ratio
-15.90
P/B Ratio9.34
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -100.00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -235.76M
ROE -73.93% ROA -40.87%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -142.09M
ROIC -29.07% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.29 Current Ratio 9.25
Interest Coverage -19.93 Dividend Yield 0.00%
Valuation
P/E Ratio -15.90 P/B Ratio 9.34
P/S Ratio N/A PEG Ratio -0.26
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 3.75B Enterprise Value 3.48B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0.0 6.85M 0.0 0.0 0.0
Net Income -235.76M -151.09M -216.21M -381.90M -10.66M
EPS (Diluted) -2.06 -1.57 -2.31 -4.24 -0.08
Gross Profit 0.0 6.85M 0.0 0.0 0.0
Operating Income -201.06M -171.28M -212.26M -374.87M -10.44M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 576.80M 360.25M 444.31M 629.64M 11.72M
Total Liabilities 175.25M 124.00M 108.14M 138.08M 8.62M
Shareholders' Equity 401.55M 236.24M 336.17M 491.55M 3.10M
Total Debt 117.23M 84.59M 69.80M 75.70M 5.63M
Cash & Equivalents 383.22M 128.03M 393.64M 595.08M 7.23M
Current Assets 536.41M 315.09M 437.75M 628.77M 11.17M
Current Liabilities 58.00M 39.39M 38.34M 24.64M 8.62M